News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
316,853 Results
Type
Article (13819)
Company Profile (24)
Press Release (303010)
Multimedia
Podcasts (27)
Webinars (6)
Section
Business (85762)
Career Advice (853)
Deals (20237)
Drug Delivery (43)
Drug Development (53259)
Employer Resources (53)
FDA (8772)
Job Trends (6636)
News (169092)
Policy (16153)
Tag
2024 BioCapital Digital (1)
2024 BioMidwest Digital (1)
2024 Bio NC Digital (1)
2024 Bio NC Standard (1)
2024 Biotech Bay Standard (4)
2024 Biotech Beach Digital (1)
2024 Biotech Beach Standard (1)
2024 Genetown Digital (1)
2024 Genetown Standard (4)
2024 Pharm Country Standard (2)
Academia (967)
Accelerated approval (3)
Adcomms (9)
Allergies (44)
Alliances (20418)
ALS (54)
Alzheimer's disease (829)
Antibody-drug conjugate (ADC) (56)
Approvals (8822)
Artificial intelligence (96)
Autoimmune disease (16)
Automation (4)
Bankruptcy (218)
Best Places to Work (6122)
BIOSECURE Act (4)
Biosimilars (41)
Biotechnology (23)
Bladder cancer (48)
Brain cancer (15)
Breast cancer (156)
Cancer (1396)
Cardiovascular disease (117)
Career advice (710)
Career pathing (9)
CAR-T (76)
Cell therapy (229)
Cervical cancer (15)
Clinical research (44860)
Collaboration (392)
Compensation (138)
Complete response letters (14)
COVID-19 (1265)
CRISPR (12)
C-suite (93)
Cystic fibrosis (49)
Data (1637)
Decentralized trials (1)
Depression (22)
Diabetes (216)
Diagnostics (3342)
Digital health (8)
Diversity, equity & inclusion (17)
Drug discovery (67)
Drug pricing (47)
Drug shortages (22)
Duchenne muscular dystrophy (55)
Earnings (42821)
Editorial (20)
Employer branding (5)
Employer resources (49)
Events (41398)
Executive appointments (324)
FDA (9549)
Featured Employer (9)
Friedreich's ataxia (1)
Frontotemporal dementia (5)
Funding (315)
Gene editing (44)
Generative AI (8)
Gene therapy (138)
GLP-1 (623)
Government (1628)
Grass and pollen (1)
Guidances (41)
Healthcare (8521)
Huntington's disease (12)
IgA nephropathy (14)
Immunology and inflammation (57)
Indications (20)
Infectious disease (1331)
Inflammatory bowel disease (71)
Inflation Reduction Act (3)
Influenza (25)
Intellectual property (63)
Interviews (173)
IPO (11436)
IRA (17)
Job creations (858)
Job search strategy (581)
Kidney cancer (8)
Labor market (2)
Layoffs (125)
Leadership (5)
Legal (3225)
Liver cancer (49)
Lung cancer (218)
Lymphoma (108)
Machine learning (3)
Management (22)
Manufacturing (147)
MASH (56)
Medical device (6536)
Medtech (6537)
Mergers & acquisitions (9224)
Metabolic disorders (641)
Multiple sclerosis (56)
NASH (13)
Neurodegenerative disease (35)
Neuropsychiatric disorders (10)
Neuroscience (1141)
NextGen: Class of 2025 (2281)
Non-profit (1211)
Northern California (1552)
Now hiring (1)
Obesity (393)
Opinion (108)
Ovarian cancer (57)
Pain (53)
Pancreatic cancer (67)
Parkinson's disease (89)
Partnered (10)
Patents (157)
Patient recruitment (64)
Peanut (24)
People (21023)
Pharmaceutical (10)
Pharmacy benefit managers (3)
Phase I (13411)
Phase II (20048)
Phase III (15173)
Pipeline (890)
Policy (55)
Postmarket research (1392)
Preclinical (4894)
Press Release (9)
Prostate cancer (61)
Psychedelics (12)
Radiopharmaceuticals (136)
Rare diseases (191)
Real estate (1417)
Recruiting (17)
Regulatory (12475)
Reports (13)
Research institute (913)
Resumes & cover letters (143)
Rett syndrome (4)
RNA editing (1)
RSV (19)
Schizophrenia (43)
Series A (45)
Series B (26)
Service/supplier (3)
Sickle cell disease (26)
Southern California (1322)
Special edition (3)
Spinal muscular atrophy (86)
Sponsored (11)
Startups (948)
Stomach cancer (6)
Supply chain (34)
Tariffs (9)
The Weekly (27)
United States (13025)
Vaccines (320)
Venture capitalists (14)
Weight loss (269)
Women's health (10)
Worklife (4)
Date
Today (11)
Last 7 days (278)
Last 30 days (1473)
Last 365 days (20182)
2025 (5537)
2024 (21624)
2023 (24389)
2022 (29058)
2021 (31256)
2020 (28463)
2019 (20469)
2018 (15480)
2017 (16862)
2016 (14152)
2015 (17571)
2014 (12053)
2013 (8732)
2012 (9373)
2011 (10174)
2010 (9326)
Location
Africa (285)
Alabama (38)
Alaska (4)
Arizona (53)
Arkansas (6)
Asia (20174)
Australia (3184)
California (3441)
Canada (1370)
China (330)
Colorado (150)
Connecticut (168)
Delaware (86)
Europe (40556)
Florida (589)
Georgia (90)
Idaho (16)
Illinois (247)
India (17)
Indiana (208)
Iowa (1)
Japan (100)
Kansas (57)
Kentucky (5)
Louisiana (6)
Maine (46)
Maryland (497)
Massachusetts (2315)
Michigan (130)
Minnesota (186)
Mississippi (1)
Missouri (36)
Montana (16)
Nebraska (6)
Nevada (39)
New Hampshire (47)
New Jersey (1174)
New Mexico (4)
New York (1139)
North Carolina (463)
North Dakota (2)
Northern California (1552)
Ohio (73)
Oklahoma (6)
Oregon (7)
Pennsylvania (824)
Puerto Rico (10)
Rhode Island (6)
South America (504)
South Carolina (12)
Southern California (1322)
Tennessee (59)
Texas (540)
Utah (95)
Virginia (93)
Washington D.C. (29)
Washington State (363)
West Virginia (2)
Wisconsin (16)
316,853 Results for "airstrip ob".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
FDA Clears Clarius OB AI for Handheld Ultrasound: A Leap Forward in Prenatal Care
Clarius Mobile Health, a leading provider of high-definition handheld ultrasound systems, has obtained FDA clearance for the Clarius OB AI fetal biometric measurement tool, improving access to obstetrical (OB) prenatal monitoring and care in resource-limited areas.
June 25, 2024
·
3 min read
Business
Nantworks AirStrip® and GE HealthCare Announce Agreement to Commercialize Integrated Patient Monitoring and Cardiac Data Visualization for Healthcare Systems
GE HealthCare (Nasdaq: GEHC), a leading global medical technology, pharmaceutical diagnostics and digital solutions innovator, and AirStrip, a vendor-agnostic clinical surveillance technology company and a member of the Nantworks group of AI driven companies, announced today a joint commercialization agreement.
December 4, 2023
·
5 min read
Press Releases
Autolus Therapeutics Announces FDA Approval of AUCATZYL® (obecabtagene autoleucel – obe-cel) for adults with relapsed/refractory B-cell acute lymphoblastic leukemia (r/r B-ALL)
November 11, 2024
·
18 min read
Lone Star Bio
Natera Launches Fetal RhD NIPT Supporting Ob/Gyn Physicians and Patients During RhIg Shortage
Natera, Inc., a global leader in cell-free DNA and genetic testing, announced the launch of a new cfDNA-based fetal RhD test.
May 1, 2024
·
5 min read
BioMidwest
AdventHealth Tampa Launching New OB/GYN Residency Program
AdventHealth Tampa is proud to announce the accreditation of its new Obstetrics and Gynecology Residency Program, helping improve access to women’s healthcare in the Tampa Bay region.
May 18, 2023
·
2 min read
Autolus Therapeutics Receives EMA Orphan Medical Product Designation for obe-cel for Treatment of Acute Lymphoblastic Leukemia
Autolus Therapeutics plc today announced that the European Medicines Agency (EMA) has granted obe-cel, Autolus’ leading CAR T clinical candidate, Orphan Medical Product Designation for treatment of acute lymphoblastic leukemia (ALL) patients.
March 31, 2022
·
5 min read
Podcast
Tariff Turmoil, FDA’s Future, Pfizer’s Obesity Setback and CEO Salaries Revealed
Donald Trump takes biopharma on a tariff-themed rollercoaster ride; J&J kicks off the Q1 earnings season; experts express concern about the FDA’s future; Pfizer’s obesity setback could be Viking’s gain; and BioSpace reveals the highest paid pharma CEOs.
April 16, 2025
·
1 min read
·
Heather McKenzie
Weight Loss
Viking Rises as Pfizer’s Oral Obesity Med Falters
Viking Therapeutics enjoyed a nice share rally on the news that rival Pfizer is discontinuing obesity candidate danuglipron. But the biotech has a long way to go to recover after six straight months of decline.
April 14, 2025
·
3 min read
·
Annalee Armstrong
Weight loss
Pfizer Drops Lead Obesity Asset After Liver Safety Concerns, Overall Review
Pfizer’s discontinuation of danuglipron brings the company down to a single molecule in its obesity pipeline.
April 14, 2025
·
2 min read
·
Tristan Manalac
Government
HHS Leaves Door Open to Future Medicare Coverage of Obesity Drugs
Last week, The Trump administration reversed a Biden-era proposal for Medicare coverage of anti-obesity treatments. But on Monday, HHS suggested it is open to future policy considerations toward this end.
April 8, 2025
·
2 min read
·
Tristan Manalac
1 of 31,686
Next
